Arun Gulani, an eye surgeon at the Gulani Vision Institute, who explained that there is no established treatment protocol for NAION, which is considered irreversible. However, Gulani, who was also not involved in the study, told us that Experimental treatments are being evaluated nationally and worldwide. The lead author of the recent study was Joseph Rizzo, MD, director of the Neuro-Ophthalmology Service at Mass Eye and Ear in Boston, MA
The company reported Q3 FY26 revenue of 2,903 million, a decrease from 3,926 million in Q3 FY25
The combination of bimagrumab with semaglutide has demonstrated enhanced weight loss results, highlighting the potential for innovative therapies to address both fat reduction and muscle preservation in patients
GLP-1 Weight Loss and Muscle Mass When you lose weight on GLP-1s, a lot of that weight can be lost muscle mass